MedicarePartD.guide

A non-government resource built from CMS public data

Non-statin cholesterol drugs on Prescription Blue Premium (S5584-002)

Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Michigan
Premium
$106.70/month
Deductible
None
Change plan

6 of 8 Non-statin cholesterol drugs are covered on this plan. 3 of them require prior authorization.

2 aren't on the formulary (Repatha and Vascepa).

  • ezetimibe
    generic Zetia
    Covered
    $1.03
    Tier 3
  • Praluent
    alirocumab
    Covered · prior auth
    from $124.48
    Tier 3
  • Nexletol
    bempedoic acid
    Covered · prior auth
    $109.96
    Tier 4
  • Nexlizet
    bempedoic acid and ezetimibe
    Covered · prior auth
    $109.78
    Tier 4
  • fenofibrate
    generic Tricor
    Covered
    from $0.95
    Tier 3
  • icosapent ethyl
    generic Vascepa
    Covered
    27%
    Tier 4
Not on the formulary
Repatha, Vascepa

Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list